FATENasdaq United States
Market cap
$326.366 M
$2.80 +12.45%
Close of 7 Aug 2026
Revenue
$6.65M
#3246 by revenue
Earnings
-$136.3M
Loss-making
Shares outstanding
116,559,186
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Fate Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.